Regen BioPharma Inc. (OTCMKTS:RGBP) jumped 55% last week and 595% in a month. The stock is among the micro-cap stocks to consider after RGBP made considerable gains in the past few days.
For instance, on Wednesday, the stock surged 19% after heavy interest, with the rally took its gains for last week up to 90%. The massive gain in the stock was triggered following the August 17 announcement of the receipt of approval of its cancer vaccine patent. Equally, the company is on track to receive OTC Market Pink Status, which has possibly triggered the rally.
As of September 30, 2019, the company had $7,885 in cash, but a year ago, the company had 0 cash. The cash reduction is attributed to capital spent in the operation of Regen BioPharma’s business. In addition, accounts receivables were $71,186 as of September 30, 2019, but increased to $103,192 as of September 30, 2020. With RGBP stock soaring, it is worth keeping it on the watch list.
On Friday, RGBP stock surged 11% at $0.0697 with more than 358.02 million shares, compared to its average volume of 102.89 million shares. The stock has moved within a range of $0.0630 – 0.0815 after opening the trade at $0.0695.